Cargando…

Pin1 and secondary hyperparathyroidism of chronic kidney disease: gene polymorphisms and protein levels

Background: Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (Pin1) is a key regulator of PTH mRNA stability. Secondary hyperparathyroidism (SHPT), which is characterized by elevated serum PTH levels, is a common complication of CKD. We investigated the possible associations between CKD with S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yu, Zhang, Li-Li, Ding, Fa-Xian, Cao, Ping, Qi, Yuan-Yuan, Wang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014329/ https://www.ncbi.nlm.nih.gov/pubmed/27876426 http://dx.doi.org/10.1080/0886022X.2016.1256310

Ejemplares similares

Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism
por: Ma, Haoyang, et al.
Publicado: (2020)

Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism
por: Qin, Xiachuan, et al.
Publicado: (2021)

Complications after radiofrequency ablation of hyperparathyroidism secondary to chronic kidney disease
por: Lin, Li-Ping, et al.
Publicado: (2023)

A single-center experience of parathyroidectomy in 1500 cases for secondary hyperparathyroidism: a retrospective study
por: Zhao, Shasha, et al.
Publicado: (2022)

Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis
por: Diao, Zongli, et al.
Publicado: (2016)

Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits
por: Chen, Xiu, et al.
Publicado: (2021)

The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
por: Susantitaphong, Paweena, et al.
Publicado: (2019)

Ultrasound-Guided Radiofrequency Ablation: A New Attempt to the Treatment of Refractory Hyperparathyroidism Secondary to Chronic Kidney Disease
por: Zhang, Dan-Ling, et al.
Publicado: (2021)

Association of Secondary Hyperparathyroidism with Hemoglobin Level in Patients with Chronic Kidney Disease
por: Chutia, Happy, et al.
Publicado: (2013)

Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
por: Zhang, Yi, et al.
Publicado: (2019)

Total parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: systematic review and meta-analysis
por: Li, Changjia, et al.
Publicado: (2017)

Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation
por: Mawad, Habib, et al.
Publicado: (2017)

Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Otsuka, Keiichi, et al.
Publicado: (2018)

Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism
por: Kritmetapak, Kittrawee, et al.
Publicado: (2020)

Secondary hyperparathyroidism among Nigerians with chronic kidney disease
por: Gimba, Zumnan M, et al.
Publicado: (2018)

Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management
por: Habas, Elmukhtar, et al.
Publicado: (2021)

Reduction of Halo Pin Site Morbidity with a New Pin Care Regimen
por: Kazi, Hussain Anthony, et al.
Publicado: (2013)

Skeletal findings in secondary hyperparathyroidism
por: Koratala, Abhilash, et al.
Publicado: (2017)

Total Parathyroidectomy with Subcutaneous Parathyroid Forearm Autotransplantation in the Treatment of Secondary Hyperparathyroidism: A Single-Center Experience
por: Casella, Claudio, et al.
Publicado: (2018)

Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy: a meta-analysis
por: Gao, Dan, et al.
Publicado: (2022)

Long-Term Clinical Practice Experience with Cinacalcet for Treatment of Hypercalcemic Hyperparathyroidism after Kidney Transplantation
por: Thiem, Ursula, et al.
Publicado: (2015)

Septic cavernous sinus thrombosis secondary to halo vest pin site infection
por: Rahimizadeh, Abolfazl, et al.
Publicado: (2020)

Kidney allograft failure due to acute phosphate nephropathy associated with severe secondary hyperparathyroidism
por: Wong, Ping-Nam, et al.
Publicado: (2011)

Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
por: Cheng, Steven, et al.
Publicado: (2006)

Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease
por: Naveh-Many, Tally, et al.
Publicado: (2020)

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Cunningham, John, et al.
Publicado: (2019)

(99m)Tc-MIBI SPECT/CT imaging had high sensitivity in accurate localization of parathyroids before parathyroidectomy for patients with secondary hyperparathyroidism
por: Zeng, Ming, et al.
Publicado: (2019)

Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study
por: Forni Ogna, Valentina, et al.
Publicado: (2013)

Primary hyperparathyroidism
por: Wang, Ao, et al.
Publicado: (2019)

Determinants of Secondary Hyperparathyroidism in Bariatric Patients after Roux-en-Y Gastric Bypass or Sleeve Gastrectomy: A Pilot Study
por: Alexandrou, Andreas, et al.
Publicado: (2015)

Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2020)

Secondary and Tertiary Hyperparathyroidism in Chronic Kidney Disease: An Endocrine and Renal Perspective
por: Chandran, Manju, et al.
Publicado: (2019)

Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease
por: Xu, Yang, et al.
Publicado: (2021)

Outcomes of Secondary Hyperparathyroidism in Chronic Kidney Disease and the Direct Costs of Treatment
por: Joy, Melanie S., et al.
Publicado: (2007)

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism
por: Moyes, V. J., et al.
Publicado: (2010)

Association between MPO-463G > A polymorphism and chronic kidney disease: a meta-analysis
por: Qin, Jiaxuan, et al.
Publicado: (2018)

Refractory secondary hyperparathyroidism in waiting list for parathyroidectomy: who we should operate first in a quaternary hospital in Brazil regarding survival
por: Assumpção, Lia Roque, et al.
Publicado: (2019)

Impact of parathyroidectomy among nondiabetic hemodialysis patients with severe hyperparathyroidism
por: Huang, Qing-xiu, et al.
Publicado: (2022)

Indoxyl sulfate and high-density lipoprotein cholesterol in early stages of chronic kidney disease
por: Wang, Li, et al.
Publicado: (2020)

Thyrotoxicosis Occurring in Secondary Hyperparathyroidism Patients Undergoing Dialysis after Total Parathyroidectomy with Autotransplantation
por: Xu, Zhou, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_60shm6a7bk9ovvgq6n3ejgucdi